Johnson & Johnson (JNJ)
253.28
-0.63
(-0.25%)
USD |
NYSE |
Oct 15, 16:00
254.07
+0.79
(+0.31%)
Pre-Market: 07:32
Johnson & Johnson SG&A Expense (TTM) : 19.22B for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 19.22B |
| June 30, 2026 | 25.14B |
| March 31, 2026 | 24.60B |
| December 31, 2025 | 23.68B |
| September 30, 2025 | 23.38B |
| June 30, 2025 | 22.93B |
| March 31, 2025 | 22.72B |
| December 31, 2024 | 22.87B |
| September 30, 2024 | 22.23B |
| June 30, 2024 | 22.15B |
| March 31, 2024 | 21.86B |
| December 31, 2023 | 21.51B |
| September 30, 2023 | 21.04B |
| June 30, 2023 | 20.62B |
| March 31, 2023 | 21.45B |
| December 31, 2022 | 22.48B |
| September 30, 2022 | 24.29B |
| June 30, 2022 | 25.32B |
| March 31, 2022 | 25.16B |
| December 31, 2021 | 24.66B |
| September 30, 2021 | 23.96B |
| June 30, 2021 | 23.39B |
| March 31, 2021 | 22.31B |
| December 31, 2020 | 22.08B |
| September 30, 2020 | 21.67B |
| Date | Value |
|---|---|
| June 30, 2020 | 21.61B |
| March 31, 2020 | 22.16B |
| December 31, 2019 | 22.18B |
| September 30, 2019 | 22.13B |
| June 30, 2019 | 22.30B |
| March 31, 2019 | 22.50B |
| December 31, 2018 | 22.54B |
| September 30, 2018 | 22.59B |
| June 30, 2018 | 22.47B |
| March 31, 2018 | 22.02B |
| December 31, 2017 | 21.49B |
| September 30, 2017 | 20.76B |
| June 30, 2017 | 20.11B |
| March 31, 2017 | 19.99B |
| December 31, 2016 | 19.94B |
| September 30, 2016 | 20.53B |
| June 30, 2016 | 20.84B |
| March 31, 2016 | 21.04B |
| December 31, 2015 | 21.20B |
| September 30, 2015 | 21.13B |
| June 30, 2015 | 21.52B |
| March 31, 2015 | 21.62B |
| December 31, 2014 | 21.95B |
| September 30, 2014 | 22.05B |
| June 30, 2014 | 21.90B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.24B |
| Merck & Co., Inc. | 11.14B |
| Pfizer Inc. | 13.72B |
| Bristol Myers Squibb Co. | 7.413B |
| Liquidia Corp. | 192.66M |